Agenus Inc. (AGEN) vs CapsoVision, Inc. (CV)
A side-by-side comparison of Agenus Inc. and CapsoVision, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGEN
Agenus Inc.
$7.97HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
CV
CapsoVision, Inc.
$6.38HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
Total return — AGEN vs CV
growth of $100 · dividends reinvested · last 1yAGEN +77.1% (+77.1%/yr)CV +88.3% (+88.3%/yr)CV compounded faster over this window
AGEN CV
AGEN vs CV: by the numbers
- •AGEN is the larger company ($332M vs $319M market cap).
- •AGEN is profitable (69.34% net margin) while CV runs a net loss (-214.74%).
Metrics side by side
Valuation
| Metric | AGEN | CV |
|---|---|---|
| P/E ratio | 3.01 | N/A |
| Forward P/E | 29.78 | N/A |
| P/S ratio | 2.50 | 22.94 |
| P/B ratio | N/A | 24.20 |
| EV / EBITDA | 8.64 | N/A |
Profitability
| Metric | AGEN | CV |
|---|---|---|
| Gross margin | 29.63% | 50.88% |
| Operating margin | -18.00% | -188.25% |
| Net margin | 69.34% | -214.74% |
| ROE | N/A | -226.56% |
| ROIC | N/A | -164.32% |
Growth (annualized)
| Metric | AGEN | CV |
|---|---|---|
| Revenue CAGR (5Y) | 14.13% | N/A |
| Total return CAGR (5Y) | -40.10% | N/A |
Frequently asked
- Is AGEN or CV more profitable?
- AGEN runs the higher net margin — AGEN at 69.34% versus CV at -214.74%.
Go deeper
Dig into the metrics
Agenus P/E ratioAgenus ROECapsoVision ROEAgenus operating marginCapsoVision operating marginAgenus revenue growthCapsoVision revenue growthAgenus free cash flowCapsoVision free cash flow
Agenus & CapsoVision appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.